Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric G Meissner

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Emerging Infectious Diseases|June 20, 2012
Disseminated microsporidiosis in an immunosuppressed patientEric G Meissner, John E Bennett, Yvonne Qvarnstrom, et al.
Antiviral Research|July 5, 2017
Modeling HCV cure after an ultra-short duration of therapy with direct acting agentsAshish Goyal, Yoav Lurie, Eric G Meissner, et al.
Hepatology Communications|December 5, 2017
Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infectionEric G Meissner, Anita Kohli, Jeanette Higgins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/RilpivirineStephanie E Kirk, Christina Young, Hayley Berry, et al.
Progress in Cardiovascular Diseases|February 15, 2020
Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literatureCharles Muiruri, Chris T Longenecker, Eric G Meissner, et al.
The Journal of Infectious Diseases|December 25, 2013
IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirinEric G Meissner, Dimitra Bon, Ludmila Prokunina-Olsson, et al.
Hepatology International|May 20, 2016
Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitisShikha Shrivastava, Eric G Meissner, Emily Funk, et al.
Medical Care|January 8, 2026
Lessons Learned From Using PCORnet® to Support the Pathways to Cardiovascular Disease Prevention and Impact of Specialty Referral Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States (PATHWAYS Study)Keith Marsolo, Karen Chiswell, Gretchen Sanders, et al.
AIDS Research and Human Retroviruses|November 13, 2015
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein ConcentrationKerry Townsend, Eric G Meissner, Sreetha Sidharthan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2017
Across state lines: Fulminant Babesia microti infection in a liver transplant recipientEric G Meissner, John W McGillicuddy, Jerry Squires, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Emerging Infectious Diseases|June 20, 2012
Disseminated microsporidiosis in an immunosuppressed patientEric G Meissner, John E Bennett, Yvonne Qvarnstrom, et al.
Antiviral Research|July 5, 2017
Modeling HCV cure after an ultra-short duration of therapy with direct acting agentsAshish Goyal, Yoav Lurie, Eric G Meissner, et al.
Hepatology Communications|December 5, 2017
Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infectionEric G Meissner, Anita Kohli, Jeanette Higgins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/RilpivirineStephanie E Kirk, Christina Young, Hayley Berry, et al.
Progress in Cardiovascular Diseases|February 15, 2020
Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literatureCharles Muiruri, Chris T Longenecker, Eric G Meissner, et al.
The Journal of Infectious Diseases|December 25, 2013
IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirinEric G Meissner, Dimitra Bon, Ludmila Prokunina-Olsson, et al.
Hepatology International|May 20, 2016
Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitisShikha Shrivastava, Eric G Meissner, Emily Funk, et al.
Medical Care|January 8, 2026
Lessons Learned From Using PCORnet® to Support the Pathways to Cardiovascular Disease Prevention and Impact of Specialty Referral Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States (PATHWAYS Study)Keith Marsolo, Karen Chiswell, Gretchen Sanders, et al.
AIDS Research and Human Retroviruses|November 13, 2015
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein ConcentrationKerry Townsend, Eric G Meissner, Sreetha Sidharthan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2017
Across state lines: Fulminant Babesia microti infection in a liver transplant recipientEric G Meissner, John W McGillicuddy, Jerry Squires, et al.
Pageof 8